LGC Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:LGC Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10819
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LGC Ltd (LGC), formerly LGC (Teddington) Ltd is a life sciences measurement and testing company that offers reference materials, genomics solutions and analytical testing products and services. The company’s products comprise DNA extraction instrumentation, DNA extraction kits, Douglas scientific, genotyping chemistry, genotyping instruments, genotyping libraries and others. It offers services such as genotyping, consultancy, consumer product testing, digital forensic investigation, DNA and RNA extraction services, DNA sequencing, drug and alcohol testing, drug development services, food and agricultural analytical services and others. The company caters to agrigenomics, forensic science, food, government and academia; human genomics, pharma and healthcare and sports sectors. It serves its clients in the UK and abroad. LGC is headquartered in Teddington, the UK.

LGC Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
LGC Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
LGC Ltd, Medical Devices Deals, 2012 to YTD 2018 9
LGC Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
LGC Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
LGC Genomics To Acquire Bioanalytical Sciences Business Of Quotient BioResearch 11
Venture Financing 12
Lucigen Raises USD2.2 Million in Venture Financing 12
Lucigen Raises USD1.95 Million in Venture Financing 13
Lucigen Raises US$1.7 Million In Venture Financing 14
Private Equity 15
KKR to Acquire LGC from Bridgepoint 15
Partnerships 16
Lucigen Enters into Distribution Agreement with Illumina 16
Lucigen Enters into Distribution Agreement with Sigma-Aldrich 17
EnviroLogix Enters Into Distribution Agreement With Douglas Scientific 18
Lucigen Enters Into Distribution Agreement With Research Corporation Technologies For Endotoxin Free CleanColi Expression System 19
Link Technologies Enters Into Distribution Agreement With GeneDesign 20
ChromaDex Enters Into Distribution Agreement With LGC Standards For LoGiCal Reference Standards 21
EnviroLogix Enters Into Co-Development Agreement With Douglas Scientific 22
Life Technologies Enters Into Co-Marketing Agreement With Douglas Scientific 23
Licensing Agreements 24
LGC Enters into Licensing Agreement with Keygene 24
Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 25
Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 26
Acquisition 27
LGC Acquires Axolabs 27
LGC to Acquire Biosearch Technologies 28
Biosearch Technologies Acquires Majority Stake In LightSpeed Genomics 29
LGC Ltd – Key Competitors 30
LGC Ltd – Key Employees 31
LGC Ltd – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 33
Recent Developments 34
Corporate Communications 34
Sep 22, 2017: Dr. Juergen Mueller joins LGC as Commercial and Strategic Development Director, Oligo-therapeutics 34
Legal and Regulatory 35
Jul 03, 2018: NML awarded ISO17025 accreditation for digital PCR-based quantification of DNA 35
Product News 36
Jul 05, 2017: Meridian2 delivers high throughput liquid handling for PCR 36
Jan 16, 2017: Hydrocycler2 delivers high throughput thermal cycling for PCR 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
LGC Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
LGC Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
LGC Ltd, Medical Devices Deals, 2012 to YTD 2018 9
LGC Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
LGC Genomics To Acquire Bioanalytical Sciences Business Of Quotient BioResearch 11
Lucigen Raises USD2.2 Million in Venture Financing 12
Lucigen Raises USD1.95 Million in Venture Financing 13
Lucigen Raises US$1.7 Million In Venture Financing 14
KKR to Acquire LGC from Bridgepoint 15
Lucigen Enters into Distribution Agreement with Illumina 16
Lucigen Enters into Distribution Agreement with Sigma-Aldrich 17
EnviroLogix Enters Into Distribution Agreement With Douglas Scientific 18
Lucigen Enters Into Distribution Agreement With Research Corporation Technologies For Endotoxin Free CleanColi Expression System 19
Link Technologies Enters Into Distribution Agreement With GeneDesign 20
ChromaDex Enters Into Distribution Agreement With LGC Standards For LoGiCal Reference Standards 21
EnviroLogix Enters Into Co-Development Agreement With Douglas Scientific 22
Life Technologies Enters Into Co-Marketing Agreement With Douglas Scientific 23
LGC Enters into Licensing Agreement with Keygene 24
Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 25
Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 26
LGC Acquires Axolabs 27
LGC to Acquire Biosearch Technologies 28
Biosearch Technologies Acquires Majority Stake In LightSpeed Genomics 29
LGC Ltd, Key Competitors 30
LGC Ltd, Key Employees 31
LGC Ltd, Other Locations 32
LGC Ltd, Subsidiaries 32
LGC Ltd, Joint Venture 33

List of Figures
LGC Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
LGC Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
LGC Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[LGC Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lanco Infratech Ltd:企業の戦略的SWOT分析
    Lanco Infratech Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Diamond Offshore Drilling Inc (DO)-石油・ガス分野:企業M&A・提携分析
    Summary Diamond Offshore Drilling, Inc. (Diamond Offshore) is an offshore oil and gas drilling company, which provides contract drilling services to the energy industry. It operates through a fleet of offshore drilling rigs comprising semisubmersibles, jack-ups, and dynamically positioned drillships …
  • Konami Holdings Corp:企業の戦略・SWOT・財務情報
    Konami Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary Konami Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Calamos Asset Management, Inc.:企業の戦略・SWOT・財務分析
    Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report Summary Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Pan Pacific Hotels Group Ltd:企業の戦略・SWOT・財務分析
    Pan Pacific Hotels Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Pan Pacific Hotels Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Agile Therapeutics Inc (AGRX):企業の財務・戦略的SWOT分析
    Summary Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its p …
  • Glory Ltd:企業の戦略・SWOT・財務分析
    Glory Ltd - Strategy, SWOT and Corporate Finance Report Summary Glory Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Accurate Energetic Systems, LLC:企業の戦略・SWOT・財務情報
    Accurate Energetic Systems, LLC - Strategy, SWOT and Corporate Finance Report Summary Accurate Energetic Systems, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Toppan Forms Co Ltd:企業の戦略・SWOT・財務分析
    Toppan Forms Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Toppan Forms Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Allianz Global Assistance SAS:企業の戦略・SWOT・財務情報
    Allianz Global Assistance SAS - Strategy, SWOT and Corporate Finance Report Summary Allianz Global Assistance SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • PGS ASA (PGS):企業の財務・戦略的SWOT分析
    PGS ASA (PGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Ontario Teachers’ Pension Plan:企業の戦略・SWOT・財務情報
    Ontario Teachers' Pension Plan - Strategy, SWOT and Corporate Finance Report Summary Ontario Teachers' Pension Plan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Mostostal Warszawa SA (MSW):企業の財務・戦略的SWOT分析
    Mostostal Warszawa SA (MSW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Care Hospitals:製薬・医療:M&Aディール及び事業提携情報
    Summary Care Hospitals is a healthcare service provider that offers medical care services. The center operates through its specialty departments such as anesthesiology, clinical psychology, obstetrics and gynecology, dietetics and nutrition, ophthalmology and hematology, emergency and general medici …
  • Terme Dobrna D.D.:企業の戦略・SWOT・財務分析
    Terme Dobrna D.D. - Strategy, SWOT and Corporate Finance Report Summary Terme Dobrna D.D. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Alstom SA (ALO):企業の財務・戦略的SWOT分析
    Alstom SA (ALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Seoul National University Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary Seoul National University Hospital (SNUH) is a healthcare service provider. It operates as the representative medical center of Korea. The hospital focuses on raising the standards of nation’s healthcare system, medical education, research and patient care. It offers services such as outpati …
  • UPM-Kymmene Corporation:企業の戦略・SWOT・財務情報
    UPM-Kymmene Corporation - Strategy, SWOT and Corporate Finance Report Summary UPM-Kymmene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Global Clean Energy Holdings Inc (GCEH):企業の戦略的SWOT分析
    Global Clean Energy Holdings Inc (GCEH) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • ATI Physical Therapy-製薬・医療分野:企業M&A・提携分析
    Summary ATI Physical Therapy (ATI) is a healthcare service provider that offers therapy services. The center offers therapy services such as physical therapy, workers' comp rehab, sports therapy, hand therapy, women's health, specialty therapies, home health and complimentary injury screening servic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆